Valproic acid (Valproates): Malformations and birth defects (1 reply and 2 comments)
The use of valproic acid containing medicines (valproate) in women of child bearing age is more and more questioned.
There are some actual measures in Europe for a contraindication of valproate-containing medications in pregnant woman and strong protective measures for women of child bearing potential.
Here the german text: https://thasso.com/von-neuem-valproat-haltige-arzneimittel-und-schwangerschaft/
In France, valproate-containing medicines are now definitively (effective End of June 2018) a contraindication in pregnant woman and in woman of child bearing potential, be it in Bipolar Disorder- or Epilepsy-treatment.
See here https://thasso.com/enfin-le-valproate-est-interdit-pendant-la-grossesse/, and follow the links in there for information applying to the measures taken by the European Union (EU) too.
thasso had just a new article on malformations in the course of pregnancy under therapy with valproate and other similar medications. See here (in French): https://thasso.com/grossesse-et-risques-de-malformations-il-ny-a-pas-seulement-le-valproate/